Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Kim M Fox"'
Autor:
Laurent Fauchier, Nicola Greenlaw, Roberto Ferrari, Ian Ford, Kim M Fox, Jean-Claude Tardif, Michal Tendera, Ph Gabriel Steg, CLARIFY Investigators
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0125164 (2015)
Few data are available regarding the use of antithrombotic strategies in coronary artery disease patients with atrial fibrillation (AF) in everyday practice. We sought to describe the prevalence of AF and its antithrombotic management in a contempora
Externí odkaz:
https://doaj.org/article/b06025f177d6433a954ce4916801d654
Autor:
Paul R Kalra, Xavier García-Moll, José Zamorano, Philip A Kalra, Kim M Fox, Ian Ford, Roberto Ferrari, Jean-Claude Tardif, Michal Tendera, Nicola Greenlaw, Ph Gabriel Steg, CLARIFY Investigators
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e102335 (2014)
To assess the frequency of chronic kidney disease (CKD), define the associated demographics, and evaluate its association with use of evidence-based drug therapy in a contemporary global study of patients with stable coronary artery disease.22,272 pa
Externí odkaz:
https://doaj.org/article/4e833655087b4a52b6efb5facab030d1
Autor:
Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox, CLARIFY Investigators
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e36284 (2012)
BackgroundHeart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among patients with stable CAD in routi
Externí odkaz:
https://doaj.org/article/2158c5199d7b4819ab00a35f107c5f4b
Autor:
Philippe Gabriel Steg, Deepak L Bhatt, Stefan K James, Oliver Darlington, Louise Hoskin, Tabassome Simon, Kim M Fox, Lawrence A Leiter, Shamir R Mehta, Robert A Harrington, Anders Himmelmann, Wilhelm Ridderstråle, Marielle Andersson, Héctor Bueno, Leonardo De Luca, Amarjeet Tank, Carl Mellström, Phil McEwan
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 8:777-785
Aims To conduct a health economic evaluation of ticagrelor in patients with type 2 diabetes and coronary artery disease (CAD) from a multinational payer perspective. Cost–effectiveness and cost–utility of ticagrelor were evaluated in the overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::821176274e3b416ddc33a356e212a23f
https://doi.org/10.1093/ehjcvp/pvac032
https://doi.org/10.1093/ehjcvp/pvac032
Autor:
Emmanuelle Vidal-Petiot, Yedid Elbez, Jules Mesnier, Gregory Ducrocq, Ian Ford, Michal Tendera, Roberto Ferrari, Jean-Claude Tardif, Kim M Fox, Philippe Gabriel Steg
Publikováno v:
European Journal of Preventive Cardiology.
Guidelines have lowered blood pressure (BP) targets to130/80 mmHg. We examined the benefit of intensive control for each BP component, versus the burden of other modifiable risk factors, in patients with chronic coronary syndromes (CCS).The CLARIFY r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::086d1063a28bc9e25bd713ecb97e81c8
https://doi.org/10.1093/eurjpc/zwad004
https://doi.org/10.1093/eurjpc/zwad004
Autor:
Rohit M. Oemrawsingh, K. Martijn Akkerhuis, Laura C. Van Vark, W. Ken Redekop, Goran Rudez, Willem J. Remme, Michel E. Bertrand, Kim M. Fox, Roberto Ferrari, A.H. Jan Danser, Moniek de Maat, Maarten L. Simoons, Jasper J. Brugts, Eric Boersma
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 3 (2016)
BackgroundPatients with stable coronary artery disease (CAD) constitute a heterogeneous group in which the treatment benefits by angiotensin‐converting enzyme (ACE)‐inhibitor therapy vary between individuals. Our objective was to integrate clinic
Externí odkaz:
https://doaj.org/article/6824d0c793a749909c8ab7e5d2500d7a
Autor:
Gregory Ducrocq, Deepak L. Bhatt, Jane J. Lee, Naishu Kui, Kim M. Fox, Robert A. Harrington, Lawrence A. Leiter, Shamir R. Mehta, Róbert Gábor Kiss, Stefan James, Dragos Vinereanu, Kurt Huber, Marielle Andersson, Anders Himmelmann, Tabassome Simon, Ph. Gabriel Steg
Publikováno v:
American heart journal. 249
The THEMIS trial demonstrated that in high-risk patients with stable coronary artery disease and diabetes without previous myocardial infarction or stroke, ticagrelor, in addition to aspirin, reduced the incidence of ischemic events but increased maj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d108cb2a9145b002fb4be218ba469a12
https://pubmed.ncbi.nlm.nih.gov/35321823
https://pubmed.ncbi.nlm.nih.gov/35321823
Publikováno v:
European Heart Journal. 38:2919-2922
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90e76c0f5c9ffbf426cac875730b49d3
https://doi.org/10.1093/eurheartj/ehx539
https://doi.org/10.1093/eurheartj/ehx539
Autor:
Roberto Ferrari, Athanasios J. Manolis, Mario Marzilli, Aldo P. Maggioni, Paolo G. Camici, Nicolas Danchin, Kim M. Fox, Jose Lopez-Sendon, Giuseppe M.C. Rosano, Filippo Crea
Publikováno v:
Nature Reviews Cardiology. 15:120-132
A range of drugs is available for symptomatic angina, but the optimal choice or combination of therapies is often uncertain, and contemporary guidelines do not necessarily provide definite recommendations. In this Consensus Statement, Ferrari and col
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd839539d2da57293e44398defecfab6
https://doi.org/10.1038/nrcardio.2017.131
https://doi.org/10.1038/nrcardio.2017.131
Autor:
Jean-Claude Tardif, Roberto Ferrari, Philippe Gabriel Steg, Michal Tendera, Ian Ford, Kim M. Fox, Nicola Greenlaw, Emmanuel Sorbets
Publikováno v:
Clinical Cardiology. 40:797-806
Background: Despite major advances in prevention and treatment, coronary artery disease (CAD) remains the leading cause of death worldwide. Whereas many sources of data are available on the epidemiology of acute coronary syndromes, fewer datasets ref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff79ea37fd15634cb2f500dea6fb8e09
https://doi.org/10.1002/clc.22730
https://doi.org/10.1002/clc.22730